Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C

Original Article

R. Yaeger, J. Weiss, M.S. Pelster, A.I. Spira, M. Barve, S.-H.I. Ou, T.A. Leal, T.S. Bekaii-Saab, C.P. Paweletz, G.A. Heavey, J.G. Christensen, K. Velastegui, T. Kheoh, H. Der-Torossian, and S.J. Klempner

N Engl J Med 2023;388:44-54

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
01/04/2023
Course expires: 
01/05/2025
Take course

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Take course